AETN — what changed in the latest 10-Q
A section-by-section comparison of AETN's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-19 vs the prior 10-Q · 2025-11-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +13 | −18 | ~1 | 5 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 2 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-19
On February 17, 2026, the Company entered into a merger agreement with Aeternum Health LLC, pursuant to which Aeternum Health will merge into Shorepower, with Shorepower as the surviving entity. Upon closing, Shorepower’s CEO and sole director, Jeff Kim, will resign and appoint Paul Mann, Aeternum H…
As consideration for the merger, the Company will issue shares representing 51% ownership and 2,000,000 shares of Series B preferred stock (with super voting rights) to Paul Mann. Aeternum Health will contribute assets including intellectual property and data related to a peptide-based longevity tre…
In March 2026, the Company changed its name to Aeternum Health, Inc. and its trading symbol to AETN. Effective April 3, 2026, the Company increased its authorized shares from 100 million to 250 million. The merger is subject to customary closing conditions, including receipt of the audited financial…
For the three months ended March 31, 2026 compared to the three months ended March 31, 2025
We had total revenue of $2,260 for the three months ended March 31, 2026, compared to $164,657 for the three months ended March 31, 2025, a decrease of $162,397 or 98.6%. We had costs of revenue of $13,461 and $38,383, respectively, and a deduction for revenue share of $776 and $922, respectively, f…
Text removed vs the prior filing · source: 10-Q · 2025-11-13
For the three months ended September 30, 2025 compared to the three months ended September 30, 2024
We had total revenue of $8,345 for the three months ending September 30, 2025 compared to $15,442 for the three months ended September 30, 2024, a decrease of $7,097 or 46%. We had costs of revenue of $15,527 and $28,904, respectively, and a deduction for revenue share of $1,435 and $1,422, respecti…
For the three months ending September 30, 2025, the company incurred $14,140 of professional fees compared to $13,000 for the three months ending September 30, 2024, an increase of $1,140 or 8.8%. Professional fees generally consist of audit, legal, accounting and investor relation fees. In the curr…
For the three months ended September 30, 2025, the company incurred $37,686 of general and administrative expense (“G&A”) compared to $12,045 for the three months ended September 30, 2024, an increase of $25,641 or 212.9%.
For the three months ending September 30, 2025, we recognized $10,500 of consulting expense, compared to $20,155 in the prior period, a decrease of $9,655 or 47.9%.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice